Profusa, Inc. (NASDAQ:PFSA – Free Report)’s stock is going to reverse split on the morning of Monday, February 9th. The 1-75 reverse split was announced on Thursday, February 5th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, February 6th.
Profusa Trading Down 36.4%
PFSA stock traded down $0.03 during trading on Thursday, reaching $0.05. 14,921,879 shares of the company were exchanged, compared to its average volume of 16,309,144. The firm’s 50 day moving average is $0.11. The stock has a market cap of $4.74 million, a P/E ratio of -0.02 and a beta of -0.14. Profusa has a 52-week low of $0.05 and a 52-week high of $2.40.
Profusa (NASDAQ:PFSA – Get Free Report) last posted its earnings results on Wednesday, November 19th. The company reported ($0.70) earnings per share for the quarter.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on Profusa
Profusa Company Profile
Profusa develops implantable, tissue-integrated biosensors and associated reader technology designed to provide continuous, real-time monitoring of physiological biomarkers. Its platform uses a biocompatible, porous hydrogel sensor that is placed under the skin via a minimally invasive procedure and becomes perfused with tissue; an external optical reader interrogates the sensor to convert fluorescent or optical signals into quantitative measurements such as local tissue oxygen levels. The company’s approach emphasizes long-duration sensing from a single implanted device rather than repeated spot measurements.
The technology is being positioned to support a range of clinical and commercial applications, including chronic disease management, wound and post-surgical monitoring, and clinical research where continuous molecular-level data can improve decision-making.
Featured Articles
- Five stocks we like better than Profusa
- The day the gold market broke
- NEW LAW: Congress Approves Setup For Digital Dollar?
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Profusa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profusa and related companies with MarketBeat.com's FREE daily email newsletter.
